Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93;Analyse der ursachen von todesfällen im verlauf der intensiven anfangschemotherapie in der studie AML-BFM 93

Klinische Padiatrie

Volumn 215, Issue 3, 2003, Pages 151-158

  Creutzig, Ursula ^a   Zimmermann, M ^a   Reinhardt, D ^a   Lehrnbecher, T ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

AML in children; Causes of death; Toxicity

Indexed keywords

ALLOPURINOL; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; PENICILLIN G; RASBURICASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BLEEDING; CANCER REGRESSION; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; EARLY DIAGNOSIS; FATALITY; FEMALE; HEART ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFANT; INFECTION COMPLICATION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MYCOSIS; NEUTROPENIA; NEWBORN; STEM CELL TRANSPLANTATION;

EID: 0038796904     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39374     Document Type: Article

References (28)

1. Ascioglu S, Rex JH, De Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an internatnional consensus. Clin Infect Dis 2002; 34: 7-14
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991; 78: 325-329
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lingeage (MT). A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 460-462
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 626-629
5. Bunin NJ, Kunkel K, Callihan TR. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children. Med Pediatr Oncol 1987; 15: 232-235
6. Büchner T, Hiddemann W, Wörmann B, Löffler H, Gassmann W, Haferlach T. Fonatsch C, Haase D, Schoch C, Hossfeld D, Lengfelder E, Aul C, Heyll A, Maschmeyer G, Ludwig WD, Sauerland MC, Heinecke A. Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood 1999; 93: 4116-4124
7. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, Sawitsky A, Stass S, Weinstein H, Woods WG. Report of the National Cancer Institute-sponsored workshop on definitions and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813-819
8. Creutzig U, Berthold F, Boos J, Fleischhack G, Gadner H, Gekow A, Graubner U, Henze G, Hermann J, Imbach P, Jürgens H, Kabisch H, Korholz D, Niemeyer CM, Reinhardt D, Reiter A, Ritter J, Spaar HJ, Zimmermann M. (Improved treatment results in children with AML: Results of study AML-BFM 93). Klin Pediatr 2001; 213: 175-185
9. Creutzig U, Ritter J, Budde M, Sutor A, Schellong G. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia: Associations with hyperleukocytosis and acute monocytic leukemia. Cancer 1987; 60: 3071-3079
10. Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F, Henze G, Jürgens H, Kabisch H, Havers W, Reiter A, Kluba U, Niggli F, Gadner H. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. J Clin Oncol 2001; 19: 2705-2713
11. Creutzig U, Zimmermann M, Ritter J, Henze G, Graf N, Löffler H, Schellong G. Definition of a standard-risk group in children with AML. Br J Haematol 1999; 104: 630-639
12. de Jong P, deJong M, Kuijper E, van der Lelie J. Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy. Eur J Clin Microbiol Infect Dis 1993; 12: 750-755
13. Feusner JH, Alonzo TA, Dinndorf P, Smith FO, Arceci R, Gerbing RB, Lange BJ, for the Children's Cancer Group. Infectious Complications of Intensive Chemotherapy on Children's Cancer Group Protocol CCG-2961 for Pediatric Acute Myeloid Leukemia. Blood 2002; 100: 332a-332a
14. Gamis AS, Howells WB, De Swarte-Wallace J, Feusner JH, Buckley JD, Woods WG. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891. J Clin Oncol 2000; 18: 1845-1855
15. Groll AH, Ritter J, Müller FM. (Prevention of fungal infections in children and adolescents with cancer). Klin Pädiatr 2001; 213 (Suppl 1): A50-A68
16. Kaiser J, Varwig D, Reinhardt D, Groll A, Lehrnbecher T. Variation of diagnostic and therapeutic procedures in suspected invasive fungal infections in children with AML. Klin Pädiatr 2002; 214: 264-264
17. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Groll A, Klingebiel T. Infectious Complications in children with AML: Analysis of the AML-BFM 93 Clinical Trial. Blood 2002; 100: 244b-244b
18. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331: 896-903
19. Persson L, Vikerfors T, Sjoberg L, Engervall P, Tidefelt U. Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia. Scand J Infect Dis 2000; 32: 615-621
20. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 2002; 6: 15-23
21. Riley LC, Hann IM, Wheatley K, Stevens RF. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML 10). The MCR Childhood Leukaemia Working Party. Br J Haematol 1999; 106: 436-444
22. Simon A, Fleischhack G. (Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients). Klin Paediatr 2001; 213 (Suppl 1): A9-A21
23. Simon A, Fleischhack G, Marklein G, Ritter J. (Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients). Klin Padiatr 2001; 213 (Suppl 1): A22-A37
24. Steinbach D, Dorffel W, Eggers G, Holfeld E, Kluba U, Krause I, Lauterbach I, Reiss T, Rieske K, Scharfe V, Schumacher R, Weigel H, Weinmann G, Zintl F, Hermann J. (Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87). Klin Padiatr 2001; 213: 162-168
25. Stemmler J, Wittmann GW, Hacker U, Heinemann V. Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure. Leuk Lymphoma 2002; 43: 1427-1430
26. Stevens RF, Hann IM, Wheatley K, Gray RG, on behalf of the MRC Childhood Leukaemia Working Party. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. Br J Haematol 1998; 101: 130-140
27. Thiebaut A, Thomas X, Belhabri A, Anglaret B, Archimbaud E. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol 2000; 79: 501-506
28. Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, Barnard D, Benjamin D, DeSwarte J, Kalousek D, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Childrens Cancer Group pilot study. J Clin Oncol 1993; 11: 1448-1457